Bioactive peptides have multiple conformations in solution but adopt well-defi
ned conformationsat lipid surfaces and in interactions with receptors. We have used side chain lactam cross-links to stabilizesecondary structures in the following peptide models of a conserved N-terminal domain of apolipoproteinE (cross-link periodicity in parentheses): I, H
2N-GQTLSEQVQEELLSSQVTQELRAG-COOH (no
ne);III,
H2N-GDTLKEQVQEELLSEQVKDELKAG-COOH (
i to
i + 3); IV,
H2N-GQDLSEKVQEELLESQVKDELLKAG-COOH (
i to
i + 4); IVa,
H2N-GQDLSEKVQEELLSEQVKDELLKAG-COOH (
i to
i + 4)(lactams above the sequence, potential salt bridges below the sequence). We previously demonstrated[Luo et al. (1994)
Biochemistry 33, 12367-12377; Braddock et al. (1996)
Biochemistry 35, 13975-13984] that peptide III, containing lactam cross-links between the
i and
i + 3 side chains, enhancesspecific binding of LDL via a receptor other than the LDL-receptor. Peptide III in solution consists oftwo short
![](/images/gifchars/alpha.gif)
helices con
nected by a non
![](/images/gifchars/alpha.gif)
helical segment. Here we exami
ne the hypothesis that thedomain modeled by peptide III is o
ne antipode of a conformational switch. To model another antipodeof the switch, we introduced two strategic modifications into peptide III to exami
ne structure-functionrelationships in this domain: (1) the spacing of the lactam cross-links was changed (
i to
i + 4 in peptidesIV and IVa) and (2) peptides IV and IVa contain the two alternative sequences at a site of a possibleend-capping interaction in peptide III. The structure of peptide IV, determi
ned by 2D-NMR, is
![](/images/gifchars/alpha.gif)
helicalacross its entire length. Despite the remarkable degree of structural order, peptide IV is biologicallyinactive. In contrast, peptides III and possibly IVa contain a central interruption of the
![](/images/gifchars/alpha.gif)
helix, whichappears
necessary for biological activity. These and other studies support the hypothesis that this domainis a conformational switch which, to the extent that it models apolipoprotein E itself, may modulateinteractions between apo E and its various receptors.